Bank of New York Mellon’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.37M | Buy |
198,685
+11,894
| +6% | +$361K | ﹤0.01% | 2195 |
|
|
2026
Q1 | $6.32M | Sell |
186,791
-10,102
| -5% | -$286K | ﹤0.01% | 2186 |
|
|
2025
Q4 | $5.36M | Sell |
196,893
-73,203
| -27% | -$2.57M | ﹤0.01% | 2283 |
|
|
2025
Q3 | $10.8M | Buy |
270,096
+3,442
| +1% | +$129K | ﹤0.01% | 1882 |
|
|
2025
Q2 | $8.87M | Buy |
266,654
+3,204
| +1% | +$97.1K | ﹤0.01% | 1959 |
|
|
2025
Q1 | $7.72M | Sell |
263,450
-2,064
| -0.8% | -$68.5K | ﹤0.01% | 1993 |
|
|
2024
Q4 | $8.72M | Buy |
265,514
+87,089
| +49% | +$4.09M | ﹤0.01% | 1997 |
|
|
2024
Q3 | $7.93M | Sell |
178,425
-44,726
| -20% | -$2.03M | ﹤0.01% | 2058 |
|
|
2024
Q2 | $9.62M | Buy |
223,151
+27,193
| +14% | +$981K | ﹤0.01% | 1979 |
|
|
2024
Q1 | $5.73M | Sell |
195,958
-7,803
| -4% | -$209K | ﹤0.01% | 2263 |
|
|
2023
Q4 | $4.54M | Sell |
203,761
-2,114
| -1% | -$47.4K | ﹤0.01% | 2418 |
|
|
2023
Q3 | $5.1M | Sell |
205,875
-4,071
| -2% | -$108K | ﹤0.01% | 2307 |
|
|
2023
Q2 | $5.95M | Buy |
209,946
+3,232
| +2% | +$80.4K | ﹤0.01% | 2227 |
|
|
2023
Q1 | $4.75M | Buy |
206,714
+1,047
| +0.5% | +$27.8K | ﹤0.01% | 2327 |
|
|
2022
Q4 | $5.78M | Sell |
205,667
-115,292
| -36% | -$3.25M | ﹤0.01% | 2259 |
|
|
2022
Q3 | $9.08M | Buy |
320,959
+20,410
| +7% | +$547K | ﹤0.01% | 1950 |
|
|
2022
Q2 | $6.66M | Sell |
300,549
-68,369
| -19% | -$1.54M | ﹤0.01% | 2165 |
|
|
2022
Q1 | $10.7M | Sell |
368,918
-227
| -0.1% | -$6.94K | ﹤0.01% | 2033 |
|
|
2021
Q4 | $12.1M | Buy |
369,145
+89,698
| +32% | +$3.61M | ﹤0.01% | 1995 |
|
|
2021
Q3 | $12.9M | Buy |
279,447
+1,603
| +0.6% | +$77.4K | ﹤0.01% | 1980 |
|
|
2021
Q2 | $15.3M | Buy |
277,844
+52,681
| +23% | +$2.95M | ﹤0.01% | 1883 |
|
|
2021
Q1 | $11.6M | Sell |
225,163
-11,195
| -5% | -$554K | ﹤0.01% | 2008 |
|
|
2020
Q4 | $10.2M | Sell |
236,358
-4,818
| -2% | -$190K | ﹤0.01% | 1993 |
|
|
2020
Q3 | $8.44M | Buy |
241,176
+4,770
| +2% | +$209K | ﹤0.01% | 1941 |
|
|
2020
Q2 | $12.6M | Buy |
236,406
+10,395
| +5% | +$481K | ﹤0.01% | 1695 |
|
|
2020
Q1 | $8.02M | Buy |
226,011
+8,601
| +4% | +$397K | ﹤0.01% | 1814 |
|
|
2019
Q4 | $10.4M | Buy |
217,410
+19,306
| +10% | +$730K | ﹤0.01% | 1950 |
|
|
2019
Q3 | $6.42M | Sell |
198,104
-8,040
| -4% | -$333K | ﹤0.01% | 2160 |
|
|
2019
Q2 | $10.3M | Sell |
206,144
-5,187
| -2% | -$277K | ﹤0.01% | 1950 |
|
|
2019
Q1 | $14.3M | Buy |
211,331
+1,160
| +0.6% | +$67.6K | ﹤0.01% | 1772 |
|
|
2018
Q4 | $9.69M | Sell |
210,171
-5,121
| -2% | -$316K | ﹤0.01% | 1920 |
|
|
2018
Q3 | $16.6M | Buy |
215,292
+2,559
| +1% | +$206K | ﹤0.01% | 1734 |
|
|
2018
Q2 | $17.9M | Buy |
212,733
+6,169
| +3% | +$538K | ﹤0.01% | 1670 |
|
|
2018
Q1 | $16.9M | Buy |
206,564
+32,535
| +19% | +$2.51M | ﹤0.01% | 1679 |
|
|
2017
Q4 | $9.95M | Sell |
174,029
-2,376
| -1% | -$150K | ﹤0.01% | 1987 |
|
|
2017
Q3 | $11.8M | Buy |
176,405
+6,632
| +4% | +$398K | ﹤0.01% | 1907 |
|
|
2017
Q2 | $8.73M | Buy |
169,773
+43,058
| +34% | +$2.2M | ﹤0.01% | 2048 |
|
|
2017
Q1 | $7.4M | Sell |
126,715
-1,291
| -1% | -$61.9K | ﹤0.01% | 2121 |
|
|
2016
Q4 | $5.34M | Buy |
128,006
+21,182
| +20% | +$1.11M | ﹤0.01% | 2282 |
|
|
2016
Q3 | $5.64M | Sell |
106,824
-2,142
| -2% | -$93.3K | ﹤0.01% | 2189 |
|
|
2016
Q2 | $4.56M | Sell |
108,966
-1,079
| -1% | -$53.3K | ﹤0.01% | 2251 |
|
|
2016
Q1 | $4.47M | Buy |
110,045
+8,141
| +8% | +$348K | ﹤0.01% | 2232 |
|
|
2015
Q4 | $6.62M | Sell |
101,904
-1,153
| -1% | -$75.6K | ﹤0.01% | 2064 |
|
|
2015
Q3 | $7.28M | Buy |
103,057
+23,110
| +29% | +$2.26M | ﹤0.01% | 2025 |
|
|
2015
Q2 | $8.89M | Sell |
79,947
-10,900
| -12% | -$1.17M | ﹤0.01% | 2027 |
|
|
2015
Q1 | $8.57M | Buy |
90,847
+9,810
| +12% | +$1.1M | ﹤0.01% | 2022 |
|
|
2014
Q4 | $9.08M | Buy |
81,037
+2,810
| +4% | +$251K | ﹤0.01% | 1973 |
|
|
2014
Q3 | $4.8M | Buy |
78,227
+116
| +0.1% | +$5K | ﹤0.01% | 2342 |
|
|
2014
Q2 | $3.58M | Buy |
78,111
+29,643
| +61% | +$1.21M | ﹤0.01% | 2527 |
|
|
2014
Q1 | $1.9M | Buy |
48,468
+20,813
| +75% | +$696K | ﹤0.01% | 2912 |
|
|
2013
Q4 | $662K | Buy |
27,655
+8,128
| +42% | +$185K | ﹤0.01% | 3477 |
|
|
2013
Q3 | $547K | Buy |
+19,527
| New | +$539K | ﹤0.01% | 3485 |
|
Other funds holding AGIO
EAM
SCM
PAM
CCIA
Bank of New York Mellon's AGIO Position: Q2 2026 in Review
Bank of New York Mellon increased its Agios Pharmaceuticals (AGIO) stake by 6.4% in Q2 2026, buying an estimated $361K and bringing the position to 198,685 shares worth $7.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2195.
Bank of New York Mellon first reported a position in AGIO in Q3 2013 and has held it in 52 quarters since. The position peaked at $17.9M in Q2 2018. 82 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.
- Bank of New York Mellon held 198,685 shares of Agios Pharmaceuticals worth $7.37M as of Q2 2026.
- Bank of New York Mellon bought 11,894 Agios Pharmaceuticals shares in Q2 2026, an estimated $361K.
- Agios Pharmaceuticals made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2195 holding.
- Bank of New York Mellon first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
- Bank of New York Mellon's Agios Pharmaceuticals position peaked at $17.9M in Q2 2018.
- 82 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.